Cancer drug delivery tested in healthy men

NCT ID NCT07214766

Recruiting now Knowledge-focused Sponsor: Genentech, Inc. Source: ClinicalTrials.gov ↗

Summary

This study aims to compare two different injection methods for delivering trastuzumab, a medication used to treat certain cancers. It will involve 312 healthy male volunteers to see if both methods deliver the drug similarly into the body and to check for side effects. The goal is to gather information, not to treat any disease in the participants.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Anaheim Clinical Trials
RECRUITING

Anaheim, California, 92801, United States
Daytona Beach Clinical Rsch Unit
RECRUITING

Daytona Beach, Florida, 32117, United States
Fortrea Clinical Research Unit - Dallas
RECRUITING

Dallas, Texas, 75247, United States
QPS Bio-Kinetic
RECRUITING

Springfield, Missouri, 65802-4842, United States

Conditions

Explore the condition pages connected to this study.

HEALTHY PARTICIPANTS